Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2017 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | International Braz J Urol (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000500849 |
Resumo: | ABSTRACT Objectives: To evaluate the prognosis of non-metastatic T3a renal cell carcinoma (RCC) with partial nephrectomy (PN). Patients and Methods: We retrospectively evaluated 125 patients with non-metastatic T3a RCC. Patients undergoing PN and radical nephrectomy (RN) were strictly matched by clinic-pathologic characteristics. Log-rank test and Cox regression model were used for univariate and multivariate analysis. Results: 18 pair patients were matched and the median follow-up was 35.5 (10-86) months. PN patients had a higher postoperative eGFR than RN patients (P=0.034). Cancer-specific survival (CSS) and recurrence-free survival (RFS) did not differ between two groups (P=0.305 and P=0.524). On multivariate analysis, CSS decreased with positive surgical margin and anemia (both P <0.01) and RFS decreased with Furhman grade, positive surgical margin, and anemia (all P<0.01). Conclusions: For patients with non-metastatic pT3a RCC, PN may be a possible option for similar oncology outcomes and better renal function. |
id |
SBU-1_c15eb270b906ca03d36768df52048bd5 |
---|---|
oai_identifier_str |
oai:scielo:S1677-55382017000500849 |
network_acronym_str |
SBU-1 |
network_name_str |
International Braz J Urol (Online) |
repository_id_str |
|
spelling |
Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward?CarcinomaRenal CellNephrectomyPatientsABSTRACT Objectives: To evaluate the prognosis of non-metastatic T3a renal cell carcinoma (RCC) with partial nephrectomy (PN). Patients and Methods: We retrospectively evaluated 125 patients with non-metastatic T3a RCC. Patients undergoing PN and radical nephrectomy (RN) were strictly matched by clinic-pathologic characteristics. Log-rank test and Cox regression model were used for univariate and multivariate analysis. Results: 18 pair patients were matched and the median follow-up was 35.5 (10-86) months. PN patients had a higher postoperative eGFR than RN patients (P=0.034). Cancer-specific survival (CSS) and recurrence-free survival (RFS) did not differ between two groups (P=0.305 and P=0.524). On multivariate analysis, CSS decreased with positive surgical margin and anemia (both P <0.01) and RFS decreased with Furhman grade, positive surgical margin, and anemia (all P<0.01). Conclusions: For patients with non-metastatic pT3a RCC, PN may be a possible option for similar oncology outcomes and better renal function.Sociedade Brasileira de Urologia2017-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000500849International braz j urol v.43 n.5 2017reponame:International Braz J Urol (Online)instname:Sociedade Brasileira de Urologia (SBU)instacron:SBU10.1590/s1677-5538.ibju.2016.0598info:eu-repo/semantics/openAccessPeng,DingHe,Zhi-songLi,Xue-songTang,QiZhang,LeiYang,Kai-weiYu,Xiao-tengZhang,Cui-jianZhou,Li-quneng2017-11-17T00:00:00Zoai:scielo:S1677-55382017000500849Revistahttp://www.brazjurol.com.br/ONGhttps://old.scielo.br/oai/scielo-oai.php||brazjurol@brazjurol.com.br1677-61191677-5538opendoar:2017-11-17T00:00International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU)false |
dc.title.none.fl_str_mv |
Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward? |
title |
Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward? |
spellingShingle |
Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward? Peng,Ding Carcinoma Renal Cell Nephrectomy Patients |
title_short |
Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward? |
title_full |
Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward? |
title_fullStr |
Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward? |
title_full_unstemmed |
Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward? |
title_sort |
Partial nephrectomy for T3aN0M0 renal cell carcinoma: shall we step forward? |
author |
Peng,Ding |
author_facet |
Peng,Ding He,Zhi-song Li,Xue-song Tang,Qi Zhang,Lei Yang,Kai-wei Yu,Xiao-teng Zhang,Cui-jian Zhou,Li-qun |
author_role |
author |
author2 |
He,Zhi-song Li,Xue-song Tang,Qi Zhang,Lei Yang,Kai-wei Yu,Xiao-teng Zhang,Cui-jian Zhou,Li-qun |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Peng,Ding He,Zhi-song Li,Xue-song Tang,Qi Zhang,Lei Yang,Kai-wei Yu,Xiao-teng Zhang,Cui-jian Zhou,Li-qun |
dc.subject.por.fl_str_mv |
Carcinoma Renal Cell Nephrectomy Patients |
topic |
Carcinoma Renal Cell Nephrectomy Patients |
description |
ABSTRACT Objectives: To evaluate the prognosis of non-metastatic T3a renal cell carcinoma (RCC) with partial nephrectomy (PN). Patients and Methods: We retrospectively evaluated 125 patients with non-metastatic T3a RCC. Patients undergoing PN and radical nephrectomy (RN) were strictly matched by clinic-pathologic characteristics. Log-rank test and Cox regression model were used for univariate and multivariate analysis. Results: 18 pair patients were matched and the median follow-up was 35.5 (10-86) months. PN patients had a higher postoperative eGFR than RN patients (P=0.034). Cancer-specific survival (CSS) and recurrence-free survival (RFS) did not differ between two groups (P=0.305 and P=0.524). On multivariate analysis, CSS decreased with positive surgical margin and anemia (both P <0.01) and RFS decreased with Furhman grade, positive surgical margin, and anemia (all P<0.01). Conclusions: For patients with non-metastatic pT3a RCC, PN may be a possible option for similar oncology outcomes and better renal function. |
publishDate |
2017 |
dc.date.none.fl_str_mv |
2017-10-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000500849 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382017000500849 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/s1677-5538.ibju.2016.0598 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Urologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Urologia |
dc.source.none.fl_str_mv |
International braz j urol v.43 n.5 2017 reponame:International Braz J Urol (Online) instname:Sociedade Brasileira de Urologia (SBU) instacron:SBU |
instname_str |
Sociedade Brasileira de Urologia (SBU) |
instacron_str |
SBU |
institution |
SBU |
reponame_str |
International Braz J Urol (Online) |
collection |
International Braz J Urol (Online) |
repository.name.fl_str_mv |
International Braz J Urol (Online) - Sociedade Brasileira de Urologia (SBU) |
repository.mail.fl_str_mv |
||brazjurol@brazjurol.com.br |
_version_ |
1750318075802025984 |